BPC-157 is a healing & recovery peptide. Typical research dosing is once or twice daily, and the body of supporting research is preclinical (extensive).
How to source BPC-157 in the Philippines
BPC-157 is not registered with FDA Philippines and is not available at any local pharmacy. Buyers source 5mg and 10mg lyophilized vials through research peptide suppliers shipping cold-chain to NAIA. Always verify a third-party COA per batch before reconstituting.
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found naturally in human gastric juice. It has been studied extensively in rodent models and is one of the most popular healing peptides in our peptide library.
It has earned the nickname "the Wolverine peptide" due to its remarkable ability to accelerate healing of muscles, tendons, ligaments, and gut tissue. Users consistently report dramatically accelerated recovery from injuries, surgeries, and chronic pain conditions. For systemic healing, many stack BPC-157 with TB-500.
BPC-157 works through multiple pathways — promoting angiogenesis (new blood vessel formation), modulating growth factors, and having systemic anti-inflammatory effects. For gut-specific inflammation, KPV is another option to consider. BPC-157 has a strong safety profile in animal studies with no LD50 established (meaning no lethal dose was found).
Angiogenesis Promotion: BPC-157 stimulates the formation of new blood vessels (angiogenesis), which is critical for delivering oxygen and nutrients to damaged tissue. This is one of the primary mechanisms behind its rapid healing effects.
Growth Factor Modulation: BPC-157 upregulates growth hormone receptors and promotes the synthesis of growth factors including VEGF, which drives tissue regeneration.
Nitric Oxide Pathway: BPC-157 activates the NO-cGMP pathway, improving blood flow to injured areas and reducing inflammation.
Gut-Brain Axis: BPC-157 modulates the vagus nerve and has protective effects on the entire gastrointestinal tract, making it useful for IBS, leaky gut, NSAID-induced damage, and IBD.
BPC-157 has no Philippine pharmaceutical equivalent. It is not registered with FDA Philippines, not stocked at Mercury Drug or Watsons, and not prescribed at hospital pharmacies. Every BPC-157 protocol running in the country is research-grade.
Most Manila-based users source 5mg or 10mg lyophilized vials from local suppliers shipping cold-chain via Lalamove same-day to Salcedo, Legazpi, BGC, Rockwell, and Quezon City. Cebu and Davao routes use airline-courier with overnight cold packs. Verified third-party COA per batch is the minimum quality bar — peptide content varies wildly between unverified suppliers, and BPC-157 is a common target for low-dose adulteration because users rarely notice missed effect on a 4-week tendon-healing protocol.
Self-directed BPC-157 protocols often run alongside a sports-medicine or orthopedic consult at Makati Med, St. Luke's BGC, or The Medical City — typically PHP 1,800–3,500 for the consult plus PHP 4,500–8,500 for an MRI if injury staging is needed. The clinic doesn't prescribe the peptide itself but provides imaging and recovery markers.
Makati Medical Center — sports medicine · Makati
Imaging and recovery monitoring; will not prescribe research peptides
St. Luke's Medical Center BGC — orthopedics · BGC
MRI and rehab medicine; concierge program for expat athletes
The Medical City — orthopedics · Pasig
Strong sports-medicine department; affordable imaging
Asian Hospital — sports medicine · Alabang
South Metro option
Not applicable — no retail availability · —
Research-grade only; verify COA per batch from supplier
| Item | PHP | USD | Source |
|---|---|---|---|
| Research-grade BPC-157 5mg vial | ₱1,800–2,800 | $32–50 | Local supplier with COA, May 2026 |
| Research-grade BPC-157 10mg vial | ₱2,800–4,500 | $50–80 | Bulk pricing |
| Sports medicine consult | ₱1,800–3,500 | $32–63 | Makati Med / St. Luke's BGC |
| MRI single joint (musculoskeletal) | ₱8,500–14,000 | $152–250 | Makati Med imaging center |
Customs & import reality
BPC-157 imported as research material is generally tolerated by BOC at personal-use volumes (under 30 vials per shipment) when invoiced as "research peptide" rather than by name. The compound is not a scheduled substance under PH law, but unregistered injectables can still be detained at NAIA inspection. Most suppliers cover one reshipment if a BOC seizure occurs — confirm policy in writing before ordering.
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Systemic (injection) | 250–500mcg | Once daily | 4–8 weeks |
| Injury-targeted | 250–500mcg | Twice daily near injury site | 4–6 weeks |
| Gut Protocol | 500mcg | Once daily (oral or sub-q) | 4–8 weeks |
| Maintenance | 250mcg | Once daily | Ongoing as needed |
Always start at the lowest effective dose and titrate up gradually.
Some users notice reduced inflammation and pain within the first week. Gut users may notice improvements in bloating and regularity quickly.
Most users report noticeable improvements in injury pain, mobility, and recovery. Tendon/ligament injuries typically show the most dramatic early improvement.
Significant tissue repair. Many users report resolving injuries that had been chronic for months or years. Quality of life improvements notable.
Most users complete their protocol. Some cycle off and resume when needed for new injuries. Long-term use is not thought to be necessary after healing.
Sourcing partner
Most readers of this site order from Primara Labs, which ships verified research-grade BPC-157 20mg across the Philippines with same-day Metro Manila delivery. New customers get 10% off the first order.
View BPC-157 on Primara LabsSee our community-verified supplier list with COA verification and cold-chain shipping to the Philippines.
Citations supporting the clinical claims on this page. Each entry links to the primary record.
BPC-157 mechanism review — angiogenesis and tendon healing
ReviewSikiric P et al. "Brain-Gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Curr Neuropharmacol 2016;14(8):857-865.
DOI: 10.2174/1570159X13666160502153022BPC-157 Achilles tendon outcomes — rat model
MechanismKrivic A et al. "Achilles detachment in rat and stable gastric pentadecapeptide BPC 157." J Orthop Res 2006;24(5):982-989.
DOI: 10.1002/jor.20096BPC-157 corticosteroid-impaired wound healing
MechanismTkalcevic VI et al. "Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression." Eur J Pharmacol 2007;570(1-3):212-221.
DOI: 10.1016/j.ejphar.2007.05.072BPC-157 muscle injury and growth hormone receptor expression
MechanismChang CH et al. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." J Appl Physiol 2011;110(3):774-780.
DOI: 10.1152/japplphysiol.00945.2010FDA bulk drug substance review — 503A compounding
LabelUS FDA. "Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act." Decision: BPC-157 not on the 503A allowed list.
SourceRisk · Disclosure · Editorial Status
This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician — ideally one with peptide-specific clinical experience — before starting any compound, adjusting a dose, or discontinuing therapy.
In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.
Editorial Status
Independent · Non-clinical
Affiliation
Not a clinic · Not a pharmacy
Last Updated
May 7, 2026
